Joachim L. Weischenfeldt

Copenhagen, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 87 publications

Somatic RUNX1 exonic deletions in myelodysplastic syndrome: A rare yet high-risk recurrent genetic aberration.

Somatic RUNX1 exonic deletions in myelodysplastic syndrome: A rare yet high-risk recurrent genetic aberration.

Journal: HemaSphere

Published: May 13, 2026

Single-cell and spatial RNA sequencing in prostate cancer.

Single-cell and spatial RNA sequencing in prostate cancer.

Journal: Nature reviews. Urology

Published: April 13, 2026

Hemizygous loss of helicases promotes genomic instability and cancer development.

Hemizygous loss of helicases promotes genomic instability and cancer development.

Journal: Science advances

Published: February 20, 2026

Mosaic Chromosomal Alterations Identify Ultra-High Risk Clonal Hematopoiesis in Patients With Lymphoma Undergoing Intensive Chemotherapy.

Mosaic Chromosomal Alterations Identify Ultra-High Risk Clonal Hematopoiesis in Patients With Lymphoma Undergoing Intensive Chemotherapy.

Journal: American journal of hematology

Published: January 29, 2026

SENIPERA Phase 0/1 randomized window-of-opportunity clinical trial of SENIcapoc and PERAmpanel mono- and combination therapy of newly diagnosed glioblastoma: a trial protocol.

SENIPERA Phase 0/1 randomized window-of-opportunity clinical trial of SENIcapoc and PERAmpanel mono- and combination therapy of newly diagnosed glioblastoma: a trial protocol.

Journal: BMC cancer

Published: November 25, 2025

Circular RNA expression landscapes in myelodysplastic neoplasms: Associations with mutational signatures and disease progression.

Circular RNA expression landscapes in myelodysplastic neoplasms: Associations with mutational signatures and disease progression.

Journal: Molecular oncology

Published: November 20, 2025

Combined Patch-clamp Electrophysiology and Single-Cell Genomic Analysis Reveal Spiking Tumor Cells at the Neocortical Glioblastoma Interface in Humans.

Combined Patch-clamp Electrophysiology and Single-Cell Genomic Analysis Reveal Spiking Tumor Cells at the Neocortical Glioblastoma Interface in Humans.

Journal: Neuro-oncology

Published: September 24, 2025

Combined patch-clamp electrophysiology and single-cell genomic analysis reveal spiking tumor cells at the neocortical glioblastoma interface in humans.

Combined patch-clamp electrophysiology and single-cell genomic analysis reveal spiking tumor cells at the neocortical glioblastoma interface in humans.

Journal: Neuro-oncology

Published: September 24, 2025

PTEN Deletions Are Associated With Tumor Progression But Unrelated to Patient Prognosis in Muscle-Invasive Urothelial Bladder Carcinomas: A Large Multi-Center Validation Study on 2710 Urothelial Bladder Carcinomas.

PTEN Deletions Are Associated With Tumor Progression But Unrelated to Patient Prognosis in Muscle-Invasive Urothelial Bladder Carcinomas: A Large Multi-Center Validation Study on 2710 Urothelial Bladder Carcinomas.

Journal: Genes, chromosomes & cancer

Published: August 28, 2025

Clinical, radiological, and molecular insights into extracranial metastases from adult gliomas.

Clinical, radiological, and molecular insights into extracranial metastases from adult gliomas.

Journal: Neuro-oncology

Published: August 22, 2025

Genomic heterogeneity drives distinct infiltration patterns in glioblastoma.

Genomic heterogeneity drives distinct infiltration patterns in glioblastoma.

Journal: Acta neuropathologica communications

Published: June 26, 2025

Spatial transcriptomic analysis reveals lack of response to PD-1 blockade in recurrent glioblastoma.

Spatial transcriptomic analysis reveals lack of response to PD-1 blockade in recurrent glioblastoma.

Journal: Acta neuropathologica

Published: June 06, 2025

Showing 1-12 of 87

Last Updated: 09/26/2026